References
- Anderson M. E., Mazur A., Yang T., Roden D. M. Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J. Pharmacol. Exp. Ther. 2002; 296: 806–810, [CSA]
- Appelbaum P. C. Quinolone activity against anaerobes. Drugs 1999; 58(Suppl. 2)60–64, [PUBMED], [INFOTRIEVE]
- Ball P. Quinolone‐induced QT interval prolongation: a not‐so‐unexpected class effect. J. Antimicrob. Chemother. 2000; 45: 557–559, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ben‐David J., Zipes D. P. Torsades de pointes and proarrhythmia. Lancet 1993; 341: 1578–1582, [CROSSREF]
- Bertino J., Jr., Fish D. The safety profile of the fluoroquinolones. Clin. Ther. 2000; 22: 798–817, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Blondeau J. M. Expanded activity and utility of the new fluoroquinolones: a review. Clin. Ther. 1999; 21: 3–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Christie M. I., Smith G. W. Cardiovascular and renal hemodynamic effects of A‐68930 in the conscious dog: a comparison with fenoldopam. J. Pharmacol. Exp. Ther. 1994; 268: 565–570, [PUBMED], [INFOTRIEVE], [CSA]
- Curran M. E., Splawski I., Timothy K. W., Vincent G. M., Green E. D., Keating M. T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80: 795–803, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improve patch clamp techniques for high‐resolution current recording from cells and cell‐free membrane‐patches. Pflügers Arch. 1981; 391: 85–100, [CROSSREF]
- Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia (Berl.) 1968; 13: 222–257, [CROSSREF]
- Kang J., Wang L., Chen X. L., Triggle D. J., Rampe D. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol. Pharmacol. 2001; 59: 122–126, [PUBMED], [INFOTRIEVE], [CSA]
- Kass R. S., Davies M. P. The roles of ion channels in an inherited heart disease: molecular genetics of the long QT syndrome. Cardiovasc. Res. 1996; 32: 443–454, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Keating M. T., Sanguinetti M. C. Molecular genetic insights into cardiovascular disease. Science 1996; 272: 681–685, [PUBMED], [INFOTRIEVE]
- Lipsky B. A., Baker C. A. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin. Infect. Dis. 1999; 28: 352–364, [PUBMED], [INFOTRIEVE]
- Oliphant C. M., Green G. M. Quinolones: a comprehensive review. Am. Fam. Phys. 2002; 65: 455–464
- Roden D. M., Lazzara R., Rosen M., Schwartz P. J., Towbin J., Vincent G. M. Multiple mechanisms in the long‐QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996; 94: 1996–2012, [PUBMED], [INFOTRIEVE], [CSA]
- Sanguinetti M. C. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann. N.Y. Acad. Sci. 1999; 868: 406–413, [PUBMED], [INFOTRIEVE], [CSA]
- Stahlmann R., Lode L. Toxicity of quinolones. Drugs 1999; 58(Suppl. 2)37–42, [PUBMED], [INFOTRIEVE]
- Takayama S., Hirohashi M., Kato M., Shimada H. Toxicity of quinolone antimicrobial agents. J. Toxicol. Environ. Health 1995; 45: 1–45, [PUBMED], [INFOTRIEVE]
- Trudeau M. C., Warmke J. W., Ganetzky B., Robertson G. A. HERG, a human inward rectifier in the voltage‐gated pot channel family. Science 1995; 269: 92–95
- Truett A. A., West D. B. Validation of a radiotelemetry system for continuous blood pressure and heart rate monitoring in dogs. Lab. Anim. Sci. 1995; 45: 299–302, [PUBMED], [INFOTRIEVE], [CSA]
- Truett A. A., Borne A. T., Poincot M. A., West D. B. Autonomic control of blood pressure and heart rate in obese hypertensive dogs. Am. J. Physiol. 1996; 270: R541–R549, [PUBMED], [INFOTRIEVE]